Mia Zachary

Ocular Specialty Sales Manager at Omeros Corporation
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Chicago Area
Languages
  • Korean -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 100 - 200 Employee
    • Ocular Specialty Sales Manager
      • Aug 2014 - Present

      -Launched Omidria; the first FDA approved combination of a mydriatic agent and NSAID for intraoperative use during cataract surgery and intraocular lens replacement surgery - Observed surgeries in the OR for intraoperative consulting and communication of clinical benefits -Educated doctors , surgical staff, administration, billing, and C level executives while helping them establish new protocols and procedures in their ASC, hospital or private surgical center -Trained facilities on our buy and bill procedures and addressed any issues with billing, coding, and our unique reimbursement landscape (CMS Medicare PASS-through status & Commercial Reimbursement) Show less

    • United States
    • Medical Device
    • 1 - 100 Employee
    • Territory Sales Manager
      • Mar 2013 - Jul 2014

      Selling and implementing new protocol for ophthalmic medical device used to diagnose and manage dry eye disease, buy and bill diagnostic device. Highly skilled throughout the entire sales process from cold calling and closing to pull through, including in service, protocol implementation, and customer support. Selling and implementing new protocol for ophthalmic medical device used to diagnose and manage dry eye disease, buy and bill diagnostic device. Highly skilled throughout the entire sales process from cold calling and closing to pull through, including in service, protocol implementation, and customer support.

    • Ocular Specialty Territory Manager
      • Jan 2009 - Mar 2013

      Responsible for calling on ophthalmologists in the clinical and surgical call point to sell Bromday/Xibrom. Advanced knowledge for the anterior segment. Responsible for calling on ophthalmologists and optometrists to sell Bepreve a highly effective medication for allergic conjunctivitis Responsible for calling on ophthalmologists in the clinical and surgical call point to sell Bromday/Xibrom. Advanced knowledge for the anterior segment. Responsible for calling on ophthalmologists and optometrists to sell Bepreve a highly effective medication for allergic conjunctivitis

    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Executive Sales Consultant
      • 2005 - 2009

      Responsible for selling to gastroenterologists, rheumatologists, cardiologists, urologists, gynecologists, and neurologists for Zelnorm, Famvir, Enablex, Diovan, Lotrel, and Exelon Patch Additional call points are hospital systems, gastroenterology labs, rheumatology infusion centers, cardiology, gynecology, neurology, and urology centers Successfully launched a buy and bill medication Reclast once a year infusion indicated for osteoporosis Responsible for selling to gastroenterologists, rheumatologists, cardiologists, urologists, gynecologists, and neurologists for Zelnorm, Famvir, Enablex, Diovan, Lotrel, and Exelon Patch Additional call points are hospital systems, gastroenterology labs, rheumatology infusion centers, cardiology, gynecology, neurology, and urology centers Successfully launched a buy and bill medication Reclast once a year infusion indicated for osteoporosis

    • United States
    • Financial Services
    • 700 & Above Employee
    • Financial Advisor
      • Jul 1997 - Dec 2004

      Series 6, 7, 63, 65 certified Life, health, and disability certified Series 6, 7, 63, 65 certified Life, health, and disability certified

Education

  • University of Illinois at Urbana-Champaign
    Bachelor of Arts (B.A.), Marketing
    1991 - 1995

Community

You need to have a working account to view this content. Click here to join now